+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cell Free DNA"

Cell Free DNA (cfDNA) Testing Global Market Report 2024 - Product Thumbnail Image

Cell Free DNA (cfDNA) Testing Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
From
From
From
Genetic Testing - Global Strategic Business Report - Product Thumbnail Image

Genetic Testing - Global Strategic Business Report

  • Report
  • March 2025
  • 573 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Cell Free DNA (cfDNA) market is a subset of the genomics industry that focuses on the analysis of circulating DNA fragments in the bloodstream. It is used to detect genetic abnormalities, such as chromosomal aneuploidy, and to monitor cancer progression. cfDNA testing is also used to detect fetal genetic abnormalities during pregnancy. The cfDNA market is expected to grow rapidly in the coming years, driven by increasing demand for non-invasive prenatal testing and the development of new technologies. The market is also expected to benefit from the increasing availability of cfDNA testing kits and the growing awareness of its potential applications. Notable companies in the cfDNA market include Illumina, Thermo Fisher Scientific, Qiagen, Natera, and Guardant Health. Show Less Read more